v3.25.2
Insider Trading Arrangements
 3 Months Ended
Jun. 30, 2025
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Item 5. Other Information.

 

The following table discloses any officer (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended) or director who adopted a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the three months ended June 30, 2025:

Name and Title

Type of Trading Arrangement

Action Taken (Date of Action)

Duration or End Date

Aggregate Number of Securities to be Sold

Description of Trading Arrangement

Jared Gollob

Chief Medical Officer

Trading plan intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5- 1(c)

Adoption (June 2, 2025)

December 31, 2026

111,997

Exercises of vested stock options and sales of shares of the Company’s common stock pursuant to the terms of the trading plan

Other than as disclosed above, no other officer or director adopted, modified or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the three months ended June 30, 2025.
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
NonRule10b51Arr Modified Flag false
Rule10b51Arr Modified Flag false
Jared Gollob [Member]  
Trading Arrangements, by Individual  
Name Jared Gollob
Title Chief Medical Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date June 2, 2025
Expiration Date December 31, 2026
Arrangement Duration 577 days
Aggregate Available 111,997